Clinical Solutions
Enabling clinicians to diagnose and monitor neurodegenerative conditions, earlier.
CDM Insights unlocks the power of microstructure and provides clinicans with a complete assessment of brain changes.
Volumetric analysis often miss the subtle alterations that signal early disease progression. Our first clinical product, CDM Insights, measures microstructural change in the cerebral cortex, providing clinicians with accurate and detailed insights for both early detection and ongoing monitoring.
CDM Insights
Evaluate MRI scans with unmatched precision
CDM Insights delivers microstructural information about the cerebral cortex, as well as cortical thickness and regional volumes alongside white matter hyper-/hypointensity volume. All in a single report.
- Quantitative analysis of brain structures
- Comprehensive reporting
- Compatible with standard MRI scanners
Early detection
CDM Insights offers a unique perspective on the cerebral cortex, combining novel metrics on microstructure and cortical thickness with macrostructural data of disease-specific brain regions. CDM Insights detects microstructural changes supporting clinicians to consider early detection.
The complete story
Our report delivers a comprehensive assessment of a patient’s brain health over time by tracking both whole-brain and regional metrics across multiple time points. Leveraging normative comparisons, CDM Insights highlights deviations from expected values, enabling a deeper understanding of neurodegenerative conditions and supporting accurate clinical evaluation.
From scan to solution
CDM Insights integrates with your PACS to process standard anatomical and diffusion MRI data in a secure cloud environment. We are ISO 13485 and ISO 27001 certified, and compliant with GDPR and HIPAA data privacy standards. Clinicians typically receive access to CDM Insights report within 12 hours of scan upload, enabling timely patient care.
Relevant Media & Publications
CDM demonstrates clinical utility for MCI subjects who are Amyloid and Tau negative
|
Detection of Alzheimer’s Disease using cortical diffusion tensor imaging.
|
Cortical diffusivity investigation in posterior cortical atrophy and typical Alzheimer’s disease.
|
Using diffusion tensor imaging to detect cortical changes in fronto-temporal dementia subtypes.
|
